TY - JOUR
T1 - Addressing pain in people living with cystic fibrosis
T2 - Cystic fibrosis foundation evidence-informed guidelines
AU - The Committee on Pain in CF.
AU - Dellon, E. P.
AU - Allada, G.
AU - Allgood, S. J.
AU - Georgiopoulos, A. M.
AU - Goggin, J. L.
AU - Hadjiliadis, D.
AU - Lowman, J. D.
AU - Madge, S.
AU - Middour-Oxler, B.
AU - Muirhead, C.
AU - Noel, M.
AU - Wilson, P.
AU - Hempstead, S. E.
AU - Faro, A.
AU - Kavalieratos, D.
AU - Freedman, Steven D.
AU - Hatziagorou, Elpis
AU - Hovater, Cade
AU - Hunsberger, Joann B.
AU - Ladores, Sigrid
AU - Lawson, Emily
AU - Madej, Marcin
AU - Millard, Jessica
AU - Raffensperger, Kasey
AU - Tallarico, Erin
N1 - Publisher Copyright:
© 2024
PY - 2025/3
Y1 - 2025/3
N2 - Even as many outcomes for people living with cystic fibrosis (PLwCF) improve, individuals still experience extensive symptom burdens. From birth, many PLwCF experience both pain as a symptom of their CF disease and procedural pain, posing detriments to health, functioning, and quality of life. Despite its prevalence and impact, there is no CF-specific guidance for the assessment and management of pain. Similarly, no guidance exists regarding communication with PLwCF about their pain experiences or its impact on their lives. Therefore, the Cystic Fibrosis Foundation (CFF) assembled an expert panel of clinicians, researchers, PLwCF, and caregivers to develop consensus recommendations for pain management in CF. We utilized literature review and expert opinion to develop 13 recommendations addressing pain assessment, management, and communication. Recommendations are centered on guiding principles of utilizing a multimodal approach to pain management, offering age and developmentally appropriate assessment and interventions, concurrently treating underlying conditions causing, contributing to, and/or exacerbated by pain, considering societal stigma of the pain experience, particularly for minoritized and marginalized people, and sensitivity to issues of access and cost. These recommendations are intended to guide clinicians in managing pain and improving quality of life for PLwCF with pain at all stages of illness and development.
AB - Even as many outcomes for people living with cystic fibrosis (PLwCF) improve, individuals still experience extensive symptom burdens. From birth, many PLwCF experience both pain as a symptom of their CF disease and procedural pain, posing detriments to health, functioning, and quality of life. Despite its prevalence and impact, there is no CF-specific guidance for the assessment and management of pain. Similarly, no guidance exists regarding communication with PLwCF about their pain experiences or its impact on their lives. Therefore, the Cystic Fibrosis Foundation (CFF) assembled an expert panel of clinicians, researchers, PLwCF, and caregivers to develop consensus recommendations for pain management in CF. We utilized literature review and expert opinion to develop 13 recommendations addressing pain assessment, management, and communication. Recommendations are centered on guiding principles of utilizing a multimodal approach to pain management, offering age and developmentally appropriate assessment and interventions, concurrently treating underlying conditions causing, contributing to, and/or exacerbated by pain, considering societal stigma of the pain experience, particularly for minoritized and marginalized people, and sensitivity to issues of access and cost. These recommendations are intended to guide clinicians in managing pain and improving quality of life for PLwCF with pain at all stages of illness and development.
KW - Cystic fibrosis
KW - Lung transplant
KW - Pain
KW - Palliative care
UR - http://www.scopus.com/inward/record.url?scp=85211389467&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85211389467&partnerID=8YFLogxK
U2 - 10.1016/j.jcf.2024.11.012
DO - 10.1016/j.jcf.2024.11.012
M3 - Review article
C2 - 39645476
AN - SCOPUS:85211389467
SN - 1569-1993
VL - 24
SP - 224
EP - 235
JO - Journal of Cystic Fibrosis
JF - Journal of Cystic Fibrosis
IS - 2
ER -